X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1285) 1285
Publication (96) 96
Book Review (25) 25
Conference Proceeding (8) 8
Book Chapter (7) 7
Paper (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
strontium ranelate (976) 976
osteoporosis (717) 717
index medicus (650) 650
humans (565) 565
strontium (440) 440
female (380) 380
postmenopausal women (316) 316
animals (311) 311
endocrinology & metabolism (278) 278
ranelate (256) 256
bone density conservation agents - therapeutic use (246) 246
postmenopausal osteoporosis (216) 216
orthopedics (214) 214
bone-mineral density (208) 208
fractures (201) 201
aged (189) 189
women (187) 187
risk (185) 185
materials science, biomaterials (173) 173
rats (173) 173
in-vitro (170) 170
thiophenes - therapeutic use (169) 169
bones (168) 168
osteoporosis - drug therapy (167) 167
bone (163) 163
rheumatology (156) 156
male (153) 153
osteoporosis, postmenopausal - drug therapy (151) 151
nonvertebral fractures (150) 150
vertebral fracture (146) 146
medicine & public health (141) 141
engineering, biomedical (136) 136
middle aged (136) 136
bisphosphonates (135) 135
bone density - drug effects (133) 133
organometallic compounds - therapeutic use (132) 132
risk factors (132) 132
calcium (127) 127
differentiation (126) 126
analysis (123) 123
drug therapy (118) 118
resorption (116) 116
alendronate (112) 112
pharmacology & pharmacy (112) 112
endocrinology (111) 111
thiophenes - pharmacology (110) 110
bone density (104) 104
hydroxyapatite (103) 103
biomedical materials (102) 102
bone density conservation agents - pharmacology (100) 100
fracture (100) 100
research (100) 100
bone mineral density (97) 97
strontium - chemistry (96) 96
biocompatibility (95) 95
aged, 80 and over (94) 94
hip fracture (94) 94
health aspects (92) 92
care and treatment (90) 90
strontium - pharmacology (87) 87
zoledronic acid (86) 86
teriparatide (85) 85
denosumab (84) 84
parathyroid-hormone (84) 84
mice (82) 82
prevention (81) 81
osteogenesis - drug effects (79) 79
density (78) 78
osteoblasts (78) 78
treatment (76) 76
bone-formation (75) 75
treatment outcome (74) 74
diphosphonates - therapeutic use (73) 73
osteogenesis (73) 73
vertebral fractures (73) 73
fractures, bone - prevention & control (72) 72
organometallic compounds - pharmacology (71) 71
mineralization (70) 70
rats, sprague-dawley (70) 70
calcium-sensing receptor (69) 69
osteoarthritis (69) 69
osteoblast differentiation (68) 68
randomized-trial (67) 67
vertebral fracture risk (66) 66
osseointegration (64) 64
osteoblasts - cytology (64) 64
mineral density (62) 62
bone density conservation agents - adverse effects (61) 61
osteoblast (61) 61
medicine, general & internal (59) 59
osteoblasts - drug effects (59) 59
biomaterials (58) 58
osteoporosis, postmenopausal - complications (56) 56
ovariectomy (56) 56
cells (54) 54
musculoskeletal diseases (54) 54
parathyroid hormone (54) 54
bone and bones - drug effects (53) 53
medicine, research & experimental (53) 53
osteoblasts - metabolism (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1173) 1173
French (29) 29
German (24) 24
Spanish (20) 20
Russian (14) 14
Turkish (10) 10
Czech (8) 8
Polish (6) 6
Slovak (5) 5
Chinese (2) 2
Portuguese (2) 2
Slovenian (2) 2
Croatian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Atencion Primaria, ISSN 0212-6567, 01/2016, Volume 48, Issue 1, pp. 49 - 53
Objective To analyse the impact of a strategy on the suitability of strontium ranelate, and its level of acceptance, after issuing recommendations based on... 
Adequacy | Stromtium ranelate | Alert
Journal Article
Osteoporosis International, ISSN 0937-941X, 6/2015, Volume 26, Issue 6, pp. 1667 - 1671
Osteoporosis accounts for about 3 % of total European health-care spending. The low proportion of costs for the pharmacological prevention of osteoporotic... 
Osteoporosis | Treatment | Medicine & Public Health | Orthopedics | Rheumatology | Strontium ranelate | Efficacy | Safety | Endocrinology
Journal Article
Nauchno-Prakticheskaya Revmatologiya, ISSN 1995-4484, 2018, Volume 56, Issue 4, pp. 429 - 432
Journal Article
Clinical Cases in Mineral and Bone Metabolism, ISSN 1724-8914, 09/2014, Volume 11, Issue 3, pp. 201 - 207
Osteoporosis is a highly prevalent condition characterized by decreases in bone mass and microarchitectural alterations. Bone fractures, especially of the hip... 
Strontium ranelate | Vitamin D | Denosumab | Bisphosphonates | Teriparatide | bisphosphonates | teriparatide | strontium ranelate | Mini-Review | vitamin D | denosumab
Journal Article
Rheumatology International, ISSN 0172-8172, 05/2010, Volume 30, Issue 7, pp. 863 - 869
Journal Article
Bone, ISSN 8756-3282, 2011, Volume 50, Issue 1, pp. 350 - 356
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 08/2009, Volume 13, Issue 8b, pp. 2189 - 2199
Age‐related osteopenia is characterized by a negative balance between bone resorption and formation. The anti‐osteoporotic drug strontium ranelate was found to... 
replication | ERK1/2 | apoptosis | osteoblasts | Akt | strontium ranelate | calcium sensing receptor | Strontium ranelate | Replication | Calcium sensing receptor | Osteoblasts | Apoptosis
Journal Article
Bone and Joint Journal, ISSN 2049-4394, 03/2017, Volume 99B, Issue 3, pp. 295 - 302
Aims Treatment guidelines for atypical femoral fractures associated with bisphosphonates have not been established. We conducted a systematic review of the... 
SURGERY | INSUFFICIENCY FRACTURES | BIOMECHANICAL PROPERTIES | SHAFT FRACTURES | SUPPRESSED BONE TURNOVER | MICRODAMAGE ACCUMULATION | STRONTIUM RANELATE | STRESS-FRACTURES | SUBTROCHANTERIC FRACTURE | ORTHOPEDICS | LONG-TERM TREATMENT | FEMUR FRACTURES
Journal Article
Journal of Materials Science, ISSN 0022-2461, 08/2017, Volume 52, Issue 15, pp. 9014 - 9022
Journal Article
ACS Nano, ISSN 1936-0851, 10/2009, Volume 3, Issue 10, pp. 3228 - 3234
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1276 - 1287
Summary Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that results in fragility fractures. With an... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SCLEROSTIN ANTIBODY | BONE-MINERAL DENSITY | CALCIUM-SENSING RECEPTOR | HUMAN OSTEOBLASTIC CELLS | OSTEOPROTEGERIN LIGAND | CATHEPSIN-K INHIBITOR | STRONTIUM RANELATE | VERTEBRAL FRACTURE | HEALTHY POSTMENOPAUSAL WOMEN | FRACTURE RISK | Wnt Proteins - drug effects | Vitamin D Deficiency - complications | Calcium - metabolism | Bone Morphogenetic Proteins - immunology | Humans | Middle Aged | Osteoporosis - diagnosis | Osteoporosis, Postmenopausal - metabolism | Antibodies, Monoclonal - therapeutic use | Osteoporosis - drug therapy | Wnt Proteins - metabolism | Biphenyl Compounds - therapeutic use | Osteoporosis - etiology | Bone Remodeling - drug effects | Antibodies, Monoclonal, Humanized | Osteoporosis - metabolism | Vitamin D Deficiency - therapy | Aged, 80 and over | Bone Resorption - metabolism | Diphosphonates - therapeutic use | Female | Benzodioxoles - therapeutic use | RANK Ligand - therapeutic use | Anabolic Agents - therapeutic use | Osteoporosis - prevention & control | Risk Assessment | Osteoporotic Fractures - prevention & control | Risk Factors | Bone Resorption - drug therapy | Bone Density Conservation Agents - therapeutic use | Denosumab | Absorptiometry, Photon | Genetic Markers - immunology | Osteoclasts - metabolism | Osteoporosis, Postmenopausal - drug therapy | Randomized Controlled Trials as Topic | Bone Density - drug effects | Quinazolines - therapeutic use | Aged | Osteoblasts - metabolism | Intercellular Signaling Peptides and Proteins - immunology | Osteoporosis | Complications and side effects | Care and treatment | Diagnosis | Bones | Vitamin D | Womens health | Metabolic disorders | Cathepsin K | Cytokines | Proteinase | Socio-economic aspects | SOST protein | Osteoblasts | Post-menopause | Bone resorption | NF- Kappa B protein | Bone mass | Fractures | Reviews | Aging | Monoclonal antibodies | Osteoclasts | Dkk1 protein | Osteogenesis | Communication
Journal Article